Egyptian National Cancer Institute Biobank, Egypt

Registration Status: Completed

Objective: The Egyptian National Cancer Institute (ENCI) biobank received the award of Centers of Excellence Grant, funded from the Egyptian Science and Technology Development Fund (STDF) of the Ministry of State for Scientific Research. ENCI biobank is affiliated to National Cancer Institute (NCI), Cairo University. Biobanking activities including the collection, storage and use of human biospecimens and associated data, conducted in a structured way that respects the individuals and maintains privacy and confidentiality. Samples of High quality, highly annotated, consented, and patient linked are stored and distributed for research purpose for the benefit of the patient and population.

Registered Biobank Name	Egyptian National Cancer Institute Biobank
Biobank Leader	Iman Gouda Farahat
Country	Egypt
Email for biobank inquiries	iman.farahat@nci.cu.edu.eg
Principal Investigator	Iman Gouda Farahat
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).